Skip to main content
Top
Published in: Infection 4/2020

01-08-2020 | Respiratory Syncytial Virus Infection | Original Paper

Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study

Authors: François Bénézit, Paul Loubet, Florence Galtier, Charlotte Pronier, Nezha Lenzi, Zineb Lesieur, Stéphane Jouneau, Gisèle Lagathu, Anne-Sophie L’Honneur, Vincent Foulongne, Christine Vallejo, Sophie Alain, Xavier Duval, Nawal Houhou, Yolande Costa, Philippe Vanhems, Sélilah Amour, Fabrice Carrat, Bruno Lina, Odile Launay, Pierre Tattevin, The FLUVAC Study Group

Published in: Infection | Issue 4/2020

Login to get access

Abstract

Purpose

To describe the burden, and characteristics, of influenza-like illness (ILI) associated with non-influenza respiratory viruses (NIRV).

Methods

We performed a prospective, multicenter, observational study of adults admitted with ILI during three influenza seasons (2012–2015). Patients were screened for picornavirus, respiratory syncytial virus (RSV), coronavirus, human metapneumovirus, adenovirus, bocavirus, parainfluenza virus, and influenza, by PCR on nasopharyngeal samples. We excluded patients coinfected with NIRV and influenza.

Results

Among 1421 patients enrolled, influenza virus was detected in 535 (38%), and NIRV in 215 (15%), mostly picornavirus (n = 61), RSV (n = 53), coronavirus 229E (n = 48), and human metapneumovirus (n = 40). In-hospital mortality was 5% (NIRV), 4% (influenza), and 5% (no respiratory virus). As compared to influenza, NIRV were associated with age (median, 73 years vs. 68, P = 0.026), chronic respiratory diseases (53% vs. 45%, P = 0.034), cancer (14% vs. 9%, P = 0.029), and immunosuppressive drugs (21% vs. 14%, P = 0.028), and inversely associated with diabetes (18% vs. 25%, P = 0.038). On multivariable analysis, only chronic respiratory diseases (OR 1.5 [1.1–2.0], P = 0.008), and diabetes (OR 0.5 [0.4–0.8], P = 0.01) were associated with NIRV detection.

Conclusions

NIRV are common in adults admitted with ILI during influenza seasons. Outcomes are similar in patients with NIRV, influenza, or no respiratory virus.
Literature
13.
14.
go back to reference Ambrosioni J, Bridevaux P-O, Wagner G, Mamin A, Kaiser L. Epidemiology of viral respiratory infections in a tertiary care centre in the era of molecular diagnosis, Geneva, Switzerland, 2011–2012. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20:O578–584. https://doi.org/10.1111/1469-0691.12525.CrossRef Ambrosioni J, Bridevaux P-O, Wagner G, Mamin A, Kaiser L. Epidemiology of viral respiratory infections in a tertiary care centre in the era of molecular diagnosis, Geneva, Switzerland, 2011–2012. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20:O578–584. https://​doi.​org/​10.​1111/​1469-0691.​12525.CrossRef
21.
go back to reference Muller LMAJ, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AIM, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis Off Publ Infect Dis Soc Am 2005;41:281–8. https://doi.org/10.1086/431587 Muller LMAJ, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AIM, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis Off Publ Infect Dis Soc Am 2005;41:281–8. https://​doi.​org/​10.​1086/​431587
Metadata
Title
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study
Authors
François Bénézit
Paul Loubet
Florence Galtier
Charlotte Pronier
Nezha Lenzi
Zineb Lesieur
Stéphane Jouneau
Gisèle Lagathu
Anne-Sophie L’Honneur
Vincent Foulongne
Christine Vallejo
Sophie Alain
Xavier Duval
Nawal Houhou
Yolande Costa
Philippe Vanhems
Sélilah Amour
Fabrice Carrat
Bruno Lina
Odile Launay
Pierre Tattevin
The FLUVAC Study Group
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01388-1

Other articles of this Issue 4/2020

Infection 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.